Poland· PL-100354315
Raxone
A idebenone product containing idebenonum, registered in Poland by Chiesi Farmaceutici S.p.A.. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Idebenone is registered in 12 of 19 countries.
Countries holding a registration under ATC N06BX13 (idebenone), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Idebenone · ATC N06BX13
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of idebenone costs, country by country.
Normalised to the WHO defined daily dose (0.9 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Idebenone · price per daily dose (0.9 g)
USD · FX 28 Sept 2026
- IT Italy$395.68
The record
At a glance
URPL (Poland)- Active substance
- Idebenonum
- Manufacturer
- Chiesi Farmaceutici S.p.A.
- Country
- Poland (PL)
- ATC code
- N06BX13
- ATC class
- Idebenone
- Defined daily dose
- 0.9 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991498610
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Idebenone in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandRaxoneChiesi Farmaceutici S.p.A.
- CzechiaRAXONEChiesi Farmaceutici S.p.A., Parma
- SpainRAXONE 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULAChiesi Farmaceutici S.P.A.
- FranceRAXONE 150 mg, comprimé pelliculéCHIESI FARMACEUTICI
- IrelandRaxone 150 mg film-coated tabletsChiesi Farmaceutici S.p.A.
- IcelandRaxoneChiesi Farmaceutici S.p.A.*
- NetherlandsRaxone 150 mg filmomhulde tablettenChiesi Farmaceutici S.p.A.
- NorwayRaxoneChiesi Farmaceutici S.p.a.
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Iceland · Raxone
- Liechtenstein · Raxone
- Norway · Raxone
- Portugal · Amizal, Cerestabon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7cad02be-8d1b-4fcb-8b5c-a03c5a109c93 GET /v1/drugs/7cad02be-8d1b-4fcb-8b5c-a03c5a109c93?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "150 mg",
"packaging": "05909991498610 ¦ Rpz ¦ EU/1/15/1020/001 ¦ 111085\n1 butelka 180 tabl.",
"substance": "Idebenonum 150 mg",
"common_name": "Idebenonum",
"pl_product_id": "100354315",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about idebenone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.